Adams Street Partners seeks to invest in early to mid-stage medical device companies attacking large markets with proprietary, therapeutic devices that have clear clinical and economic benefits over current treatments. Important considerations include the capital efficiency of obtaining regulatory approval, reimbursement, and impact on the way medicine is practiced. Particular areas of interest include devices that help treat cardiovascular, orthopedic, metabolic, and central nervous system disease, as well as devices that seek to enhance aesthetics and life style.
Companies:
- Aesthera
Photopneumatic therapy device
- CardioVention
Cardiopulmonary bypass systems
- Heartport
Minimally invasive cardiac surgery devices
- Luminous Medical, Inc
Tight Glucose Control
- NxStage Medical
Hemofiltration for kidney failure
- PneumRx
Pulmonary surgical instruments
- Proteus Biomedical
Cardiac diagnostic devices
- Revascular Therapeutics
Chronic Total Occlusion (CTO) device
- Revivant
Automated CPR Technology
- Sensys Medical
Medical diagnostic instruments
- Spinal Dynamics
Spinal disk prosthetic device
- TriReme Medical
Bifurcation stents
- USGI Medical
Developer of technologies to enable Incisionless Surgery
- Vivant Medical
Tools for breast cancer treatment
- Xtent
Drug eluting stent system